テレメディシン市場- 世界の産業規模、シェア、動向、機会、予測、コンポーネント別、展開モード別、タイプ別、技術別、提供モード別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

テレメディシンの世界市場規模は、2024年に942億8,000万米ドルとなり、予測期間中のCAGRは15.00%で、2030年には2,181億1,000万米ドルに達すると予測されています。

テレメディシンは、ヘルスケア機関、診療所、熟練看護機関などで活用され、治療提供の効率性を高めています。テレメディシンソフトウェアを通じて、臨床医は電子カルテ、人工知能診断、医療ストリーミングデバイスなどの機能を活用し、診断や治療を支援することができます。この進歩により、ヘルスケアサービスへのアクセスが限られている患者でも、自宅にいながら医師に相談できるようになりました。さらに、医療ストリーミングガジェットの導入は、高齢者の高齢化を促進しています。さらに、テレメディシンは、患者が混雑した待合室で身をさらす必要性をなくし、伝染病の蔓延を最小限に抑えるのに役立っています。テレメディシンは、通信ネットワークインフラを活用することで、テレビ会議、携帯電話、様々な媒体を利用した健康診断や診察などの遠隔ヘルスケアサービスを可能にします。対面診療が困難な緊急時のライフラインとして重要なサービスです。患者と医療従事者間の効果的なコミュニケーションを可能にし、質の高いケアの提供を保証します。

大手企業が手を組み、革新的なケアモデルに投資することで、よりアクセスしやすく、効率的で、患者中心のヘルスケアを提供するための環境が変わりつつあります。2024年4月のMedStar HealthとDispatch Healthの協業は、退院したばかりの患者に急性期医療を直接提供することを目的としたもので、戦略的イニシアチブがテレメディシンのリーチとインパクトをいかに拡大しているかを示しています。

市場促進要因

慢性疾患の増加

主な市場課題

技術導入のための高コスト

主な市場動向

ヘルスケア産業における進歩の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のテレメディシン市場に与える影響

第5章 顧客の声

第6章 世界のテレメディシン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • コンポーネント別（ソフトウェアとサービス、ハードウェア）
  • 展開モード別（クラウド、オンプレミス）
  • タイプ別（テレホスピタル、mヘルス、テレホーム）
  • 技術別（ストア＆フォワード、リアルタイム、その他）
  • 提供モード別（オーディオビジュアル、オーディオのみ、書面）
  • 用途別（テレサイキアトリー、一般診察、テレラジオロジー、テレパソロジー、その他）
  • エンドユーザー別（患者、医療提供者、支払者）
  • 地域別
  • 企業別（2024）
• 市場マップ

第7章 アジア太平洋地域のテレメディシン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第8章 欧州のテレメディシン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第9章 北米のテレメディシン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第10章 南米のテレメディシン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第11章 中東・アフリカのテレメディシン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第12章 市場力学

• 促進要因
• 課題

第13章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第14章 世界のテレメディシン市場：SWOT分析

第15章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第16章 PESTEL分析

第17章 競合情勢

• IBM Corporation
• Allscripts Healthcare Solutions Inc.
• AMD Global Telemedicine Inc.
• Resideo Technologies Inc.
• Koninklijke Philips NV
• Medtronic PLC
• Teladoc Health Inc.（InTouch Technologies Inc.）
• Cerner Corporation
• CISCO Systems Inc.
• SnapMD, Inc.

第18章 戦略的提言

第19章 調査会社について・免責事項

Global Telemedicine Market was valued at USD 94.28 Billion in 2024 and is expected to reach USD 218.11 billion by 2030 with a CAGR of 15.00% during the forecast period. Telemedicine is utilized by healthcare organizations, medical offices, and skilled nursing institutions to enhance the efficiency of treatment delivery. Through telemedicine software, clinicians can leverage features such as electronic medical records, artificial intelligence diagnostics, and medical streaming devices to aid in diagnosis and treatment. This advancement has enabled patients with limited access to healthcare services to consult with physicians from the comfort of their homes. Additionally, the introduction of medical streaming gadgets has facilitated aging in place for seniors. Moreover, telemedicine helps minimize the spread of contagious diseases by eliminating the need for patients to expose themselves in crowded waiting rooms. By leveraging the telecommunications network infrastructure, telemedicine enables remote healthcare services such as health evaluations and consultations using video conferencing, cell phones, and various mediums. This crucial service serves as a lifeline in emergency situations where in-person visits are not feasible. It enables effective communication between patients and healthcare practitioners, ensuring quality care delivery.

As leading organizations join forces and invest in innovative care models, the landscape is being reshaped to deliver more accessible, efficient, and patient-centered healthcare. The collaboration between MedStar Health and Dispatch Health in April 2024-designed to bring acute care directly to recently discharged patients-exemplifies how strategic initiatives are expanding telemedicine's reach and impact.

Key Market Drivers

Rise in Number Of Chronic Ailments

The prevalence of various chronic diseases, including cardiac arrest, cancer, respiratory disorders, injuries, diabetes, Alzheimer's disease, influenza and pneumonia, kidney disease, and septicemia, among others, is rapidly increasing. This rise in chronic diseases has resulted in an increased need for virtual medical consultations and treatment options. Telemedicine, with its convenience and accessibility, is gaining significant traction as a viable solution.

Furthermore, there is a growing awareness among patients and their family members about the importance of preventing Hospital Acquired Infections (HAI). These infections, such as Bloodstream Infection (BSI), pneumonia, Urinary Tract Infection (UTI), and Surgical Site Infection (SSI), can have severe consequences on patient health. As a result, the demand for telemedicine services continues to grow, as patients seek to minimize their risk of exposure to these infections. The telemedicine market is experiencing substantial revenue growth due to these factors, as more individuals recognize the benefits of virtual consultations and the need for preventive measures in healthcare settings.

Key Market Challenges

High cost for adoption of the technology

Implementing telemedicine services requires a robust technological infrastructure, encompassing various elements such as high-speed internet connectivity, secure data storage, and reliable telecommunication networks. These crucial components ensure seamless and efficient delivery of remote healthcare services. However, it is important to note that the initial setup costs associated with establishing such an infrastructure can be substantial, acting as a potential barrier, particularly for smaller healthcare providers or those operating in resource-constrained areas.

To effectively implement telemedicine solutions, healthcare facilities need to invest in telemedicine-specific equipment and devices, including telemedicine carts for mobile consultations, remote monitoring tools for real-time patient data collection, and video conferencing systems for virtual doctor-patient interactions. While these technological advancements offer numerous benefits, they can also come with a significant price tag, further adding to the overall cost of adopting telemedicine.

Key Market Trends

Growing Advancements in The Healthcare Industry

The introduction of cutting-edge innovations such as machine learning, Internet of Things (IoT), and artificial intelligence (AI) is set to revolutionize the industry, presenting tremendous opportunities for growth and development. These advancements will not only enhance the efficiency and effectiveness of telemedicine but also pave the way for new and innovative healthcare solutions.

Furthermore, the integration of seamless communication technologies will play a pivotal role in driving the global telemedicine market, as it will enable healthcare providers to offer remote medical services with ease and convenience. This will be particularly beneficial in bridging the gap between urban and rural areas, ensuring that healthcare services are accessible to all. Overall, the convergence of technological advancements and the increasing focus on extending healthcare services to underserved areas are key factors propelling the growth of the global telemedicine market in the foreseeable future.

Key Market Players

• IBM Corporation
• Allscripts Healthcare Solutions Inc.
• AMD Global Telemedicine Inc.
• Resideo Technologies Inc.
• Koninklijke Philips NV
• Medtronic PLC
• Teladoc Health Inc. (InTouch Technologies Inc.)
• Cerner Corporation
• CISCO Systems Inc.
• SnapMD, Inc.

Report Scope:

In this report, the Global Telemedicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Telemedicine Market, By Component:

• Software & Services
• Hardware

Telemedicine Market, By Deployment Mode:

• Cloud
• On- Premises

Telemedicine Market, By Type:

• Tele-Hospitals
• mHealth
• Tele-Homes

Telemedicine Market, By Technology:

• Store & Forward
• Real Time
• Others

Telemedicine Market, By Delivery Mode:

• Audio-Visual
• Only Audio
• Written

Telemedicine Market, By Application:

• Telepsychiatry
• General Consultations
• Teleradiology Telepathology
• Others

Telemedicine Market, By End User:

• Patients
• Providers
• Payers

Telemedicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Telemedicine Market.

Available Customizations:

Global Telemedicine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Applications
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Telemedicine Market

5. Voice of Customer

6. Global Telemedicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component (Software & Services, Hardware)
  • 6.2.2. By Deployment Mode (Cloud, On- Premises)
  • 6.2.3. By Type (Tele-Hospitals, mHealth, Tele-Homes)
  • 6.2.4. By Technology (Store & Forward, Real Time, Others)
  • 6.2.5. By Delivery Mode (Audio-Visual, Only Audio, Written)
  • 6.2.6. By Application (Telepsychiatry, General Consultations, Teleradiology Telepathology, Others)
  • 6.2.7. By End Users (Patients, Providers, Payers)
  • 6.2.8. By Region
  • 6.2.9. By Company (2024)
• 6.3. Market Map

7. Asia Pacific Telemedicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Deployment Mode
  • 7.2.3. By Type
  • 7.2.4. By Technology
  • 7.2.5. By Delivery Mode
  • 7.2.6. By Application
  • 7.2.7. By End User
  • 7.2.8. By Country
• 7.3. Asia Pacific: Country Analysis
  • 7.3.1. China Telemedicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Deployment Mode
      • 7.3.1.2.3. By Type
      • 7.3.1.2.4. By Technology
      • 7.3.1.2.5. By Delivery Mode
      • 7.3.1.2.6. By Application
      • 7.3.1.2.7. By End User
  • 7.3.2. India Telemedicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Deployment Mode
      • 7.3.2.2.3. By Type
      • 7.3.2.2.4. By Technology
      • 7.3.2.2.5. By Delivery Mode
      • 7.3.2.2.6. By Application
      • 7.3.2.2.7. By End User
  • 7.3.3. Australia Telemedicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Deployment Mode
      • 7.3.3.2.3. By Type
      • 7.3.3.2.4. By Technology
      • 7.3.3.2.5. By Delivery Mode
      • 7.3.3.2.6. By Application
      • 7.3.3.2.7. By End User
  • 7.3.4. Japan Telemedicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Deployment Mode
      • 7.3.4.2.3. By Type
      • 7.3.4.2.4. By Technology
      • 7.3.4.2.5. By Delivery Mode
      • 7.3.4.2.6. By Application
      • 7.3.1.2.7. By End User
  • 7.3.5. South Korea Telemedicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Deployment Mode
      • 7.3.5.2.3. By Type
      • 7.3.5.2.4. By Technology
      • 7.3.5.2.5. By Delivery Mode
      • 7.3.5.2.6. By Application
      • 7.3.5.2.7. By End User

8. Europe Telemedicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Deployment Mode
  • 8.2.3. By Type
  • 8.2.4. By Technology
  • 8.2.5. By Delivery Mode
  • 8.2.6. By Application
  • 8.2.7. By End User
  • 8.2.8. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Telemedicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Deployment Mode
      • 8.3.1.2.3. By Type
      • 8.3.1.2.4. By Technology
      • 8.3.1.2.5. By Delivery Mode
      • 8.3.1.2.6. By Application
      • 8.3.1.2.7. By End User
  • 8.3.2. Germany Telemedicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Deployment Mode
      • 8.3.2.2.3. By Type
      • 8.3.2.2.4. By Technology
      • 8.3.2.2.5. By Delivery Mode
      • 8.3.2.2.6. By Application
      • 8.3.2.2.7. By End User
  • 8.3.3. Spain Telemedicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Deployment Mode
      • 8.3.3.2.3. By Type
      • 8.3.3.2.4. By Technology
      • 8.3.3.2.5. By Delivery Mode
      • 8.3.3.2.6. By Application
      • 8.3.3.2.7. By End User
  • 8.3.4. Italy Telemedicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Deployment Mode
      • 8.3.4.2.3. By Type
      • 8.3.4.2.4. By Technology
      • 8.3.4.2.5. By Delivery Mode
      • 8.3.4.2.6. By Application
      • 8.3.4.2.7. By End User
  • 8.3.5. United Kingdom Telemedicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Deployment Mode
      • 8.3.5.2.3. By Type
      • 8.3.5.2.4. By Technology
      • 8.3.5.2.5. By Delivery Mode
      • 8.3.5.2.6. By Application
      • 8.3.5.2.7. By End User

9. North America Telemedicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Deployment Mode
  • 9.2.3. By Type
  • 9.2.4. By Technology
  • 9.2.5. By Delivery Mode
  • 9.2.6. By Application
  • 9.2.7. By End User
  • 9.2.8. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States Telemedicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Deployment Mode
      • 9.3.1.2.3. By Type
      • 9.3.1.2.4. By Technology
      • 9.3.1.2.5. By Delivery Mode
      • 9.3.1.2.6. By Application
      • 9.3.1.2.7. By End User
  • 9.3.2. Mexico Telemedicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Deployment Mode
      • 9.3.2.2.3. By Type
      • 9.3.2.2.4. By Technology
      • 9.3.2.2.5. By Delivery Mode
      • 9.3.2.2.6. By Application
      • 9.3.2.2.7. By End User
  • 9.3.3. Canada Telemedicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Deployment Mode
      • 9.3.3.2.3. By Type
      • 9.3.3.2.4. By Technology
      • 9.3.3.2.5. By Delivery Mode
      • 9.3.3.2.6. By Application
      • 9.3.3.2.7. By End User

10. South America Telemedicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Deployment Mode
  • 10.2.3. By Type
  • 10.2.4. By Technology
  • 10.2.5. By Delivery Mode
  • 10.2.6. By Application
  • 10.2.7. By End User
  • 10.2.8. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Telemedicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Deployment Mode
      • 10.3.1.2.3. By Type
      • 10.3.1.2.4. By Technology
      • 10.3.1.2.5. By Delivery Mode
      • 10.3.1.2.6. By Application
      • 10.3.1.2.7. By End User
  • 10.3.2. Argentina Telemedicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Deployment Mode
      • 10.3.2.2.3. By Type
      • 10.3.2.2.4. By Technology
      • 10.3.2.2.5. By Delivery Mode
      • 10.3.2.2.6. By Application
      • 10.3.2.2.7. By End User
  • 10.3.3. Colombia Telemedicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Deployment Mode
      • 10.3.3.2.3. By Type
      • 10.3.3.2.4. By Technology
      • 10.3.3.2.5. By Delivery Mode
      • 10.3.3.2.6. By Application
      • 10.3.3.2.7. By End User

11. Middle East and Africa Telemedicine Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Component
  • 11.2.2. By Deployment Mode
  • 11.2.3. By Type
  • 11.2.4. By Technology
  • 11.2.5. By Delivery Mode
  • 11.2.6. By Application
  • 11.2.7. By End User
  • 11.2.8. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Telemedicine Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Component
      • 11.3.1.2.2. By Deployment Mode
      • 11.3.1.2.3. By Type
      • 11.3.1.2.4. By Technology
      • 11.3.1.2.5. By Delivery Mode
      • 11.3.1.2.6. By Application
      • 11.3.1.2.7. By End User
  • 11.3.2. Saudi Arabia Telemedicine Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Component
      • 11.3.2.2.2. By Deployment Mode
      • 11.3.2.2.3. By Type
      • 11.3.2.2.4. By Technology
      • 11.3.2.2.5. By Delivery Mode
      • 11.3.2.2.6. By Application
      • 11.3.2.2.7. By End User
  • 11.3.3. UAE Telemedicine Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Component
      • 11.3.3.2.2. By Deployment Mode
      • 11.3.3.2.3. By Type
      • 11.3.3.2.4. By Technology
      • 11.3.3.2.5. By Delivery Mode
      • 11.3.3.2.6. By Application
      • 11.3.3.2.7. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Telemedicine Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. IBM Corporation
  • 17.1.1. Business Overview
  • 17.1.2. Company Snapshot
  • 17.1.3. Products & Services
  • 17.1.4. Financials (As Reported)
  • 17.1.5. Recent Developments
  • 17.1.6. Key Personnel Details
  • 17.1.7. SWOT Analysis
• 17.2. Allscripts Healthcare Solutions Inc.
• 17.3. AMD Global Telemedicine Inc.
• 17.4. Resideo Technologies Inc.
• 17.5. Koninklijke Philips NV
• 17.6. Medtronic PLC
• 17.7. Teladoc Health Inc. (InTouch Technologies Inc.)
• 17.8. Cerner Corporation
• 17.9. CISCO Systems Inc.
• 17.10. SnapMD, Inc.

18. Strategic Recommendations

19. About Us & Disclaimer